• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

ATRC:US

17.2300 USD 0.2800 1.65%

As of 17:20:00 ET on 07/29/2014.

Snapshot for AtriCure Inc (ATRC)

Open: 16.9700 Day's Range: 16.8600 - 17.3700 Volume: 153,790
Previous Close: 16.9500 52wk Range: 8.4800 - 23.0000 1-Yr Rtn: +80.04%

Stock Chart for ATRC

No chart data available.
  • ATRC:US 17.2400
  • 1D
  • 1M
  • 1Y
16.9500
Interactive ATRC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATRC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6812
Est. EPS (USD) (12/2014) -0.7620
Est. PEG Ratio -
Market Cap (M USD) 472.20
Shares Outstanding (M) 27.41
30 Day Average Volume 175,571
Price/Book (mrq) 3.5181
Price/Sale (ttm) 4.2906
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATRC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATRC

AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company's bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation.

Michael H Carrel "Mike"President/CEODouglas J Seith "Doug"Senior VP:Sales & Marketing
Andrew L LuxSenior VP:R&D And Ops & QAM Andrew WadeVP/CFO
More Company Profile & Key Executives for ATRC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil